Protein phosphorylation and kinases: Potential therapeutic targets in necroptosis

Eur J Pharmacol. 2024 May 5:970:176508. doi: 10.1016/j.ejphar.2024.176508. Epub 2024 Mar 15.

Abstract

Necroptosis is a pivotal contributor to the pathogenesis of various human diseases, including those affecting the nervous system, cardiovascular system, pulmonary system, and kidneys. Extensive investigations have elucidated the mechanisms and physiological ramifications of necroptosis. Among these, protein phosphorylation emerges as a paramount regulatory process, facilitating the activation or inhibition of specific proteins through the addition of phosphate groups to their corresponding amino acid residues. Currently, the targeting of kinases has gained recognition as a firmly established and efficacious therapeutic approach for diverse diseases, notably cancer. In this comprehensive review, we elucidate the intricate role of phosphorylation in governing key molecular players in the necroptotic pathway. Moreover, we provide an in-depth analysis of recent advancements in the development of kinase inhibitors aimed at modulating necroptosis. Lastly, we deliberate on the prospects and challenges associated with the utilization of kinase inhibitors to modulate necroptotic processes.

Keywords: Dephosphorylation; Human diseases; Kinase; Necroptosis; Phosphatase; Phosphorylation.

Publication types

  • Review

MeSH terms

  • Apoptosis
  • Humans
  • Necroptosis
  • Neoplasms* / drug therapy
  • Phosphorylation
  • Protein Kinases* / metabolism
  • Receptor-Interacting Protein Serine-Threonine Kinases / metabolism

Substances

  • Protein Kinases
  • Receptor-Interacting Protein Serine-Threonine Kinases